The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Chr. Hansen acquires UAS Laboratories LLC to extend the microbial platform and strengthen probiotic production flexibility
Biotics and Supplements

Chr. Hansen acquires UAS Laboratories LLC to extend the microbial platform and strengthen probiotic production flexibility

JUN 9, 2020
Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes
Biotics and Supplements

Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes

JUN 5, 2020
Kaleido Biosciences Announces Proposed Public Offering of Common Stock
Finance

Kaleido Biosciences Announces Proposed Public Offering of Common Stock

JUN 2, 2020
A Checklist for Moving an LBP Through Manufacturing: The Biotech – CDMO Relationship
Sponsored Content

A Checklist for Moving an LBP Through Manufacturing: The Biotech – CDMO Relationship

MAY 29, 2020
Viruses from poo can help combat obesity and diabetes
Pharma & Human Health

Viruses from poo can help combat obesity and diabetes

MAY 18, 2020
Modelling Biology Using Graph Language
Editor's Choice

Modelling Biology Using Graph Language

MAY 12, 2020
Compositional Data Analysis Approaches to Improve Microbiome Studies – From Collection to Conclusions
Editor's Choice

Compositional Data Analysis Approaches to Improve Microbiome Studies – From Collection to Conclusions

MAY 12, 2020
New Statistical Method Identifies Cytokines that Distinguish Stool Microbiomes
Editor's Choice

New Statistical Method Identifies Cytokines that Distinguish Stool Microbiomes

MAY 12, 2020
Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans
Clinical & Manufacturing

Intralytix Receives Multimillion-Dollar Clinical Trial Award From NIAID to Manage Shigella Infections in Humans

MAY 11, 2020
Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy
Clinical & Manufacturing

Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy

MAY 6, 2020
Microbiome after coronavirus: Investing in the power of microbes
Editor's Choice

Microbiome after coronavirus: Investing in the power of microbes

APR 30, 2020